SPECIALTY TOPICS · GUIDE
Minor Cannabinoids: CBG, CBN, CBC and Others at a Glance
A short at-a-glance guide to CBG, CBN, CBC, THCV, CBDV, CBGA, delta-8, delta-10, HHC, THCP and THC-O, with a link to a full page for each compound.
Content last updated . This page has not been medically reviewed.
Back to CBG (Cannabigerol): What It Is and What Research ShowsThe cannabinoid guide
Cannabinoids are the compounds in the cannabis plant that act on the body's own cannabinoid system. THC and CBD are the best known, but the plant makes over a hundred others. This guide takes the best-known ones one at a time: what each is, what research really shows in people, and what the risks are.
Some of them are approved medicines in some countries, some are only sold as consumer products, and some have almost no human research. Each page keeps those apart.
How to read these pages
- Every page has four tabs: About, Health, Evidence and Safety. The Safety tab is there for a reason; read it before anything else.
- Each possible use gets a certainty rating from high to insufficient, and a separate label for whether the research was in people, animals or cells.
- Studies are checked against PubMed before they are listed. Where we could not check something, the page says NOT verified.
- We do not give doses, recommend products or say that any compound treats or cures anything. Talk to a doctor or pharmacist about medicines and amounts.
- Strain names are unreliable. The lab numbers we show come from real test reports of specific samples, and the same name can have very different chemistry.
THC
Delta-9-tetrahydrocannabinolThe main compound that causes the high. Also the one with the clearest mental-health and driving risks.
CBD
CannabidiolDoes not cause a high. One prescription CBD medicine is approved for certain childhood epilepsies; shop products are a different matter.
THCA
Tetrahydrocannabinolic acidThe raw form of THC in the fresh plant. Turns into THC with heat, which is why labels list both.
CBDA
Cannabidiolic acidThe raw form of CBD in the fresh plant. Early research only, mostly in animals and cells.
CBG
CannabigerolThe parent molecule the plant uses to make the other cannabinoids. Very little human research.
CBN
CannabinolForms as THC ages. Often sold for sleep, but the sleep claims are not backed by good trials.
CBC
CannabichromeneA minor plant cannabinoid. Mostly laboratory and animal research so far.
THCV
TetrahydrocannabivarinA THC look-alike found in small amounts in some plants. Small human studies only.
CBGA
Cannabigerolic acidThe raw "mother" form the plant uses to make THCA, CBDA and CBCA.
CBDV
CannabidivarinA CBD look-alike with a shorter side chain. Mostly lab and early clinical research.
THCVA
Tetrahydrocannabivarinic acidThe raw acid form of THCV, found in small amounts in some plants.
CBGV
CannabigerovarinA rare CBG look-alike with a shorter side chain. Very little research.
More compounds (CBGA, CBDV, delta-8, HHC and others) are covered in the minor-cannabinoid pages and will get their own pages. Lab numbers are measurements of flower content, not promises about effects.
How to use this overview
Beyond THC and CBD, a 2021 review says cannabis makes over 120 other cannabinoids, all derived from the parent compound CBGA. [1] NIDA says research on the health effects of several intoxicating or related compounds, including delta-10-THC, THC-O-acetate, THCV, THCP, HHC and CBN, is limited. [2] Each paragraph below gives the short version and links to the full guide. For lesser-known names such as CBT, CBL and CBE, see CBT, CBL, CBE and other reported cannabinoids. Evidence labels used: promising but limited, insufficient evidence, preclinical (cells/animals only), no good evidence of benefit, evidence of harm and marketing claim. "Proper evidence not found" means we looked and found nothing usable.Plant cannabinoids
CBG (cannabigerol) is the precursor molecule for the most abundant plant cannabinoids. [3] One small 2024 trial in 34 healthy adults found lower anxiety and stress ratings after CBG than placebo, with no sign of impairment. [4] Label: promising but limited. Read the CBG guide.CBN (cannabinol) is often marketed for sleep. A review found no published trials using validated sleep measures and concluded there is insufficient evidence to support sleep claims. [5] Label: insufficient evidence. Read the CBN guide.
CBC (cannabichromene) is sold in some hemp products. A 2024 review says CBC products are widely used with little or no evidence of their safety or efficacy. [6] Read the CBC guide.
THCV (tetrahydrocannabivarin) was studied in a small 2016 pilot trial in type 2 diabetes, where it lowered fasting glucose compared with placebo and was well tolerated. [7] Label: promising but limited. Read the THCV guide.
CBDV (cannabidivarin) failed to beat placebo in a phase 2 trial in adults with focal seizures, where seizure reductions were similar in both groups. [8] Label: no good evidence of benefit in that trial. Read the CBDV guide.
CBGA (cannabigerolic acid) is one of the acidic precursors from which neutral cannabinoids form. [9] A 2026 review says a lack of controlled human trials holds back clinical translation. [9] Read the CBGA guide.
Converted and semisynthetic cannabinoids
These are different from plant cannabinoids and deserve more caution. Marketing percentages are not independent lab results, and none should be called safe or legal without a source.Delta-8 THC is not found in significant amounts in the plant, and concentrated products are typically manufactured from hemp-derived CBD. [10] The FDA says these products have not been evaluated or approved for safe use and it has received adverse event reports. [10] Label: evidence of harm signals. Read the delta-8 THC guide.
Delta-10 THC has very little published research. In a mouse study, one form partly substituted for delta-9 THC. [11] Human data: proper evidence not found. Read the delta-10 THC guide.
HHC (hexahydrocannabinol) is a semisynthetic derivative of THC, typically sold as a mixture of two isomers whose ratio varies widely between products. [12] It was added to Schedule II of the 1971 UN Convention on Psychotropic Substances in 2025. [13] Read the HHC guide.
THCP (tetrahydrocannabiphorol) was reported in 2019 as a natural cannabinoid with a longer side chain than THC, and it bound the CB1 receptor strongly in laboratory work. [14] Human safety data are missing. Label: preclinical (cells/animals only). Read the THCP guide.
THC-O and other acetates are semisynthetic compounds identified in some oil and herbal products. [15] Poison centers recorded 5,022 cases for delta-8, delta-10 and THC-O acetate over 2021 to 2022, almost all involving delta-8. [16] Read the THC-O and acetates guide.
Urgent: children and pets
Products that look like candy can attract children. The FDA says delta-8 products should be kept out of reach of children and pets, and to call 911 for an immediate danger to health. [10] In the US, Poison Help is 1-800-222-1222; see Poison Help by country.How to judge any minor-cannabinoid claim
Ask which compound, which study, which people, and what was measured. Laboratory and animal findings are not human results. A certificate of analysis shows content, not benefit; see how to read a cannabis COA. Laws differ widely and change; see cannabis laws by country. Related comparison: CBD vs CBG and CBD vs CBN.Frequently asked questions
Does CBN help you sleep?
A review found insufficient published evidence to support sleep claims for CBN. [5]
Is CBG better than CBD?
Proper evidence not found for a head-to-head comparison. CBG has one small healthy-adult trial. [4]
Is delta-8 THC safe?
The FDA says delta-8 THC products have not been evaluated or approved for safe use in any context. [10]
Is HHC the same as THC?
No. HHC is a semisynthetic derivative sold as a mixture of isomers. [12]
Are minor cannabinoids approved as medicines?
We did not find a regulator page approving any of the compounds in this overview. See approved cannabinoid medicines.
References
- Walsh et al. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Frontiers in pharmacology. 2021. PubMed abstract read 2026-10-22.
- National Institute on Drug Abuse (NIDA). Cannabis (Marijuana) DrugFacts. Read 2026-10-22.
- Nachnani et al. The Pharmacological Case for Cannabigerol. Journal of pharmacology and experimental therapeutics. 2021. PubMed abstract read 2026-10-22.
- Cuttler et al. Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial. Scientific reports. 2024. PubMed abstract read 2026-10-22.
- Corroon Cannabinol and Sleep: Separating Fact from Fiction. Cannabis and cannabinoid research. 2021. PubMed abstract read 2026-10-22.
- Sepulveda et al. The Potential of Cannabichromene (CBC) as a Therapeutic Agent. Journal of pharmacology and experimental therapeutics. 2024. PubMed abstract read 2026-10-22.
- Jadoon et al. Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study. Diabetes care. 2016. PubMed abstract read 2026-10-22.
- Brodie et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis and cannabinoid research. 2021. PubMed abstract read 2026-10-22.
- Singh et al. Therapeutic potential of acidic cannabinoids: an update. Journal of cannabis research. 2026. PubMed abstract read 2026-10-22.
- US Food and Drug Administration. 5 Things to Know about Delta-8 Tetrahydrocannabinol - Delta-8 THC. Read 2026-10-22.
- Wiley et al. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice. Progress in neuro-psychopharmacology and biological psychiatry. 2024. PubMed abstract read 2026-10-22.
- Nasrallah et al. Studies Pertaining to the Emerging Cannabinoid Hexahydrocannabinol (HHC). ACS chemical biology. 2023. PubMed abstract read 2026-10-22.
- UNODC Laboratory and Scientific Service. March 2025 - UNODC: Five NPS and one medicine scheduled at the 68th Session of the Commission on Narcotic Drugs. Read 2026-10-22.
- Citti et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than delta9-tetrahydrocannabinol: delta9-Tetrahydrocannabiphorol. Scientific reports. 2019. PubMed abstract read 2026-10-22.
- Tanaka et al. Identification of Acetyl, Propionyl, and Butanoyl Derivatives of THC and Its Analogs, and Their Synthetic By-Products in Oils and a Herbal Product. Drug testing and analysis. 2025. PubMed abstract read 2026-10-22.
- Burgess et al. Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America's Poison Centers. Clinical toxicology. 2024. PubMed abstract read 2026-10-22.